- Home
- MREO vs ARL Comparison
MREO vs ARL Comparison
Compare MREO & ARL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MREO
- ARL
- Stock Information
- Founded
- MREO 2015
- ARL 1999
- Country
- MREO United Kingdom
- ARL United States
- Employees
- MREO N/A
- ARL N/A
- Industry
- MREO Biotechnology: Pharmaceutical Preparations
- ARL Building operators
- Sector
- MREO Health Care
- ARL Real Estate
- Exchange
- MREO Nasdaq
- ARL Nasdaq
- Market Cap
- MREO 281.6M
- ARL 262.8M
- IPO Year
- MREO N/A
- ARL N/A
- Fundamental
- Price
- MREO $1.76
- ARL $16.43
- Analyst Decision
- MREO Strong Buy
- ARL
- Analyst Count
- MREO 5
- ARL 0
- Target Price
- MREO $7.40
- ARL N/A
- AVG Volume (30 Days)
- MREO 932.9K
- ARL 1.7K
- Earning Date
- MREO 11-11-2025
- ARL 11-06-2025
- Dividend Yield
- MREO N/A
- ARL N/A
- EPS Growth
- MREO N/A
- ARL N/A
- EPS
- MREO N/A
- ARL N/A
- Revenue
- MREO $500,000.00
- ARL $48,139,000.00
- Revenue This Year
- MREO N/A
- ARL N/A
- Revenue Next Year
- MREO $55.50
- ARL N/A
- P/E Ratio
- MREO N/A
- ARL N/A
- Revenue Growth
- MREO N/A
- ARL N/A
- 52 Week Low
- MREO $1.47
- ARL $9.43
- 52 Week High
- MREO $4.72
- ARL $18.28
- Technical
- Relative Strength Index (RSI)
- MREO 48.66
- ARL 53.39
- Support Level
- MREO $1.68
- ARL N/A
- Resistance Level
- MREO $1.88
- ARL $16.95
- Average True Range (ATR)
- MREO 0.07
- ARL 0.18
- MACD
- MREO 0.01
- ARL -0.57
- Stochastic Oscillator
- MREO 45.45
- ARL 96.65
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
About ARL American Realty Investors Inc.
American Realty Investors Inc is a fully integrated externally managed real estate company. The company operates high-quality multifamily and commercial properties throughout the Southern United States and also invests in mortgage notes receivable and in land that is either held for appreciation or development. It operates in two reportable segments; the acquisition, development, ownership and management of multifamily properties (Residential); and the acquisition, development, ownership, and management of commercial properties (Commercial), which predominantly comprise office properties. Maximum revenue is generated from its Residential segment, which includes the rental of apartments and other tenants.